Status:
COMPLETED
Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment
Lead Sponsor:
Riyadh Elm University
Conditions:
Oral Mucositis
Pediatric Cancer
Eligibility:
All Genders
3-15 years
Phase:
PHASE1
Brief Summary
The main objective of this study is to assess the impact of non-invasive photodynamic therapy by Curcumin and photo-bio-modulation low level (LL) laser treatment in managing mucositis induced by chemo...
Detailed Description
The study will be designed based on the Consolidated Standards of Reporting Trials (CONSORT) and conducted on approval from the Ethics Committee of the University. It will be a randomized controlled t...
Eligibility Criteria
Inclusion
- patients in age group of 3 years to 15 years
- mucositis (categorized \>1) based on the guidelines of WHO Toxicity Criteria
- must be able to open the mouth properly
Exclusion
- Patients with age less than 3 years and more than 15 years of age
- patients with systemic diseases
Key Trial Info
Start Date :
March 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06044142
Start Date
March 15 2023
End Date
January 30 2024
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riyadh Elm University
Riyadh, Ar Riyadh, Saudi Arabia, 1331